Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_2
1
20%
Ph not_applicable
1
20%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1
Enrolling by invitation1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting120%
enrolling_by_invitation120%
unknown240%
completed120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

NCT07746934
enrolling_by_invitation

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

NCT06216639
unknownphase_4

Bismuth Quadruple Therapy Versus Standard Triple Therapy

NCT06143124
unknownphase_3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

NCT04107194
completedphase_2

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

NCT00003151

Clinical Trials (5)

Showing 5 of 5 trials
NCT07746934Not Applicable

Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Not Yet Recruiting
NCT06216639

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

Enrolling By Invitation
NCT06143124Phase 4

Bismuth Quadruple Therapy Versus Standard Triple Therapy

Unknown
NCT04107194Phase 3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Unknown
NCT00003151Phase 2

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5